In this issue of EMBO Molecular Medicine, Uribesalgo and coworkers show that high Apelin expression correlates with poor survival in advanced breast (MMTV‐NeuT) and lung (KRASG12D) murine tumor models as well as in breast and lung cancer in humans. Here, APLN is linked to lung carcinoma.